Bioresorbable everolimus-eluting vascular scaffold treats coronary artery stenosis Cardiology Today Looking at the current best standards of drug-eluting stents, the 12-month performance of the second-generation ABSORB bioresorbable everolimus-eluting scaffold justifies the conduct of a randomized trial, new study results suggest. ... |
